Kaplan –Meier survival curve of GSE31210 comprised of 226 NSCLC patients at stage I-II demonstrated that the overall survival rate was lower in patients with higher expression of HES1 (p = 0.007) (Fig. 7A). This evidence concerns the gene HES1 and non-small cell lung carcinoma.